Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,063,211
- Value
- $96.5M
- % of portfolio
- 0.3%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,063,211 | $96.5M | 0.3% | −264,550−19.9% | Reduced | Holders |
| Q1 2026 | 1,327,761 | $136.3M | 0.4% | −250,038−15.8% | Reduced | Holders |
| Q4 2025 | 1,577,799 | $197.7M | 0.5% | −20,407−1.3% | Reduced | Holders |
| Q3 2025 | 1,598,206 | $214.1M | 0.6% | −5,099−0.3% | Reduced | Holders |
| Q2 2025 | 1,603,305 | $218.1M | 0.6% | +24,281+1.5% | Added | Holders |
| Q1 2025 | 1,579,024 | $209.5M | 0.6% | +6,940+0.4% | Added | Holders |
| Q4 2024 | 1,572,084 | $177.8M | 0.5% | −27,037−1.7% | Reduced | Holders |
| Q3 2024 | 1,599,121 | $182.3M | 0.5% | −148,799−8.5% | Reduced | Holders |
| Q2 2024 | 1,747,920 | $181.6M | 0.6% | −26,316−1.5% | Reduced | Holders |
| Q1 2024 | 1,774,236 | $201.7M | 0.6% | +34,029+2.0% | Added | Holders |
| Q4 2023 | 1,740,207 | $191.5M | 0.7% | +26,601+1.6% | Added | Holders |
| Q3 2023 | 1,713,606 | $166.0M | 0.6% | −130,373−7.1% | Reduced | Holders |
| Q2 2023 | 1,843,979 | $201.0M | 0.7% | −19,471−1.0% | Reduced | Holders |
| Q1 2023 | 1,863,450 | $188.7M | 0.8% | −73,137−3.8% | Reduced | Holders |
| Q4 2022 | 1,936,587 | $212.6M | 0.9% | +71,287+3.8% | Added | Holders |
| Q3 2022 | 1,865,300 | $180.5M | 0.8% | +24,534+1.3% | Added | Holders |
| Q2 2022 | 1,840,766 | $200.0M | 0.9% | −27,032−1.4% | Reduced | Holders |
| Q1 2022 | 1,867,798 | $221.1M | 0.8% | −33,068−1.7% | Reduced | Holders |
| Q4 2021 | 1,900,866 | $267.5M | 0.8% | +83,276+4.6% | Added | Holders |
| Q3 2021 | 1,817,590 | $214.7M | 0.7% | +46,776+2.6% | Added | Holders |
| Q2 2021 | 1,770,814 | $205.3M | 0.7% | +73,799+4.3% | Added | Holders |
| Q1 2021 | 1,697,015 | $203.4M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.